ArticleFrontiers in immunology2024

Pharmacological blockade of the mast cell MRGPRX2 receptor supports investigation of its relevance in skin disorders.

Colin H Macphee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.